<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Bioeng. Biotechnol.</journal-id>
<journal-title>Frontiers in Bioengineering and Biotechnology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Bioeng. Biotechnol.</abbrev-journal-title>
<issn pub-type="epub">2296-4185</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">778584</article-id>
<article-id pub-id-type="doi">10.3389/fbioe.2021.778584</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Bioengineering and Biotechnology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Biosynthesis of Chiral Amino Alcohols via an Engineered Amine Dehydrogenase in <italic>E.&#x20;coli</italic>
</article-title>
<alt-title alt-title-type="left-running-head">Tong et&#x20;al.</alt-title>
<alt-title alt-title-type="right-running-head">Biosynthesis of Chiral Amino Alcohols</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Tong</surname>
<given-names>Feifei</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="fn" rid="FN1">
<sup>&#x2020;</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Qin</surname>
<given-names>Zongmin</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="fn" rid="FN1">
<sup>&#x2020;</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Hongyue</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="fn" rid="FN1">
<sup>&#x2020;</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jiang</surname>
<given-names>Yingying</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Junkuan</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ming</surname>
<given-names>Hui</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Qu</surname>
<given-names>Ge</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1467956/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Xiao</surname>
<given-names>Yazhong</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Sun</surname>
<given-names>Zhoutong</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1248934/overview"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>School of Life Sciences, Anhui University</institution>, <addr-line>Hefei</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences</institution>, <addr-line>Tianjin</addr-line>, <country>China</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Department of Chemistry, School of Science, Tianjin University</institution>, <addr-line>Tianjin</addr-line>, <country>China</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Department of Life Sciences and Medicine, University of Science and Technology of China</institution>, <addr-line>Hefei</addr-line>, <country>China</country>
</aff>
<aff id="aff5">
<sup>5</sup>
<institution>National Technology Innovation Center of Synthetic Biology</institution>, <addr-line>Tianjin</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/522831/overview">Hua Ling</ext-link>, National University of Singapore, Singapore</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1485962/overview">Wen Shan Yew</ext-link>, National University of Singapore, Singapore</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1112593/overview">Lei Shao</ext-link>, Shanghai University of Medicine and Health Sciences, China</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1088544/overview">Shuke Wu</ext-link>, Huazhong Agricultural University, China</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Yazhong Xiao, <email>yzxiao@ahu.edu.cn</email>; Zhoutong Sun, <email>sunzht@tib.cas.cn</email>
</corresp>
<fn fn-type="equal" id="FN1">
<label>
<sup>&#x2020;</sup>
</label>
<p>These authors have contributed equally to this&#x20;work</p>
</fn>
<fn fn-type="other">
<p>This article was submitted to Synthetic Biology, a section of the journal Frontiers in Bioengineering and Biotechnology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>05</day>
<month>01</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2021</year>
</pub-date>
<volume>9</volume>
<elocation-id>778584</elocation-id>
<history>
<date date-type="received">
<day>17</day>
<month>09</month>
<year>2021</year>
</date>
<date date-type="accepted">
<day>15</day>
<month>11</month>
<year>2021</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2022 Tong, Qin, Wang, Jiang, Li, Ming, Qu, Xiao and Sun.</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Tong, Qin, Wang, Jiang, Li, Ming, Qu, Xiao and Sun</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these&#x20;terms.</p>
</license>
</permissions>
<abstract>
<p>Chiral amino alcohols are prevalent synthons in pharmaceuticals and synthetic bioactive compounds. The efficient synthesis of chiral amino alcohols using ammonia as the sole amino donor under mild conditions is highly desired and challenging in organic chemistry and biotechnology. Our previous work explored a panel of engineered amine dehydrogenases (AmDHs) derived from amino acid dehydrogenase (AADH), enabling the one-step synthesis of chiral amino alcohols via the asymmetric reductive amination of &#x3b1;-hydroxy ketones. Although the AmDH-directed asymmetric reduction is in a high stereoselective manner, the activity is yet fully excavated. Herein, an engineered AmDH derived from a leucine dehydrogenase from <italic>Sporosarcina psychrophila</italic> (<italic>Sp</italic>AmDH) was recruited as the starting enzyme, and the combinatorial active-site saturation test/iterative saturation mutagenesis (CAST/ISM) strategy was applied to improve the activity. After three rounds of mutagenesis in an iterative fashion, the best variant wh84 was obtained and proved to be effective in the asymmetric reductive amination of 1-hydroxy-2-butanone with 4-fold improvements in <italic>k</italic>
<sub>
<italic>cat</italic>
</sub>/<italic>K</italic>
<sub>
<italic>m</italic>
</sub> and total turnover number (TTN) values compared to those of the starting enzyme, while maintaining high enantioselectivity (<italic>ee</italic> &#x3e;99%) and thermostability (<italic>T</italic>
<sub>
<italic>50</italic>
</sub>
<sup>
<italic>15</italic>
</sup> &#x3e;53&#xb0;C). In preparative-scale reaction, the conversion of 100 and 200&#xa0;mM 1-hydroxy-2-butanone catalyzed by wh84 was up to 91&#x2013;99%. Insights into the source of an enhanced activity were gained by the computational analysis. Our work expands the catalytic repertoire and toolbox of AmDHs.</p>
</abstract>
<kwd-group>
<kwd>biosynthesis</kwd>
<kwd>protein engineering</kwd>
<kwd>directed evolution</kwd>
<kwd>amine dehydrogenase</kwd>
<kwd>chiral amino alcohol</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>As essential structural moieties, chiral &#x3b1;-amino alcohols are widely applied to produce synthetic and natural bioactive molecules (<xref ref-type="bibr" rid="B3">Ager et&#x20;al., 1996</xref>; <xref ref-type="bibr" rid="B12">Erlanson et&#x20;al., 2011</xref>). For instance, many pharmaceuticals consist of &#x3b1;-amino alcohols that serve as chiral building blocks (<xref ref-type="sec" rid="s10">Supplementary Scheme S1</xref>). Direct asymmetric reductive amination of ketones with free ammonia to produce chiral amino alcohols is a highly aspirational transformation (<xref ref-type="bibr" rid="B2">Abrahamson et&#x20;al., 2013</xref>; <xref ref-type="bibr" rid="B30">Pushpanath et&#x20;al., 2017</xref>). In the traditional chemical synthesis, it mainly relies on stoichiometric amounts of chemical reducing agents or organometallic catalysts, which are limited by low stereoselectivities, the formation of the alcohol as side product, and the requirement of extreme reaction conditions (<xref ref-type="bibr" rid="B18">Larrow et&#x20;al., 1996</xref>; <xref ref-type="bibr" rid="B5">Breuer et&#x20;al., 2004</xref>; <xref ref-type="bibr" rid="B23">Ma et&#x20;al., 2010</xref>; <xref ref-type="bibr" rid="B27">Nugent and El-Shazly, 2010</xref>; <xref ref-type="bibr" rid="B17">Karjalainen and Koskinen, 2012</xref>; <xref ref-type="bibr" rid="B47">Xie et&#x20;al., 2020</xref>; <xref ref-type="bibr" rid="B15">Hollmann et&#x20;al., 2021</xref>). Alternatively, enzymes as catalysts are increasingly explored as essential tools in asymmetric reductive aminations (<xref ref-type="bibr" rid="B35">Reetz, 2011</xref>; <xref ref-type="bibr" rid="B2">Abrahamson et&#x20;al., 2013</xref>; <xref ref-type="bibr" rid="B36">Schrittwieser et&#x20;al., 2015</xref>; <xref ref-type="bibr" rid="B9">Chen and Arnold, 2020</xref>; <xref ref-type="bibr" rid="B44">Winkler et&#x20;al., 2021</xref>). In recent years, a number of enzymes have been identified that are capable of catalyzing the asymmetric reductive amination of ketones (<xref ref-type="bibr" rid="B46">Wu et&#x20;al., 2021</xref>), including lipases (<xref ref-type="bibr" rid="B13">Francalanci et&#x20;al., 1987</xref>), acylases (<xref ref-type="bibr" rid="B43">Wang et&#x20;al., 2016</xref>), transaminases (<xref ref-type="bibr" rid="B45">Wu et&#x20;al., 2017</xref>), and imine reductases (<xref ref-type="bibr" rid="B24">Matzel et&#x20;al., 2017</xref>). Moreover, native amine dehydrogenases (AmDHs) have been identified that they can directly utilize ammonia as a sole amino source in reductive amination but with insufficient enantioselectivity (<xref ref-type="bibr" rid="B16">Itoh et&#x20;al., 2000</xref>; <xref ref-type="bibr" rid="B25">Mayol et&#x20;al., 2019</xref>).</p>
<p>Apart from the native AmDHs, the Bommarius group at Georgia Tech has engineered two natural amino acid dehydrogenases (AADHs), including a leucine dehydrogenase from <italic>Bacillus stearothermophilus</italic> (<xref ref-type="bibr" rid="B1">Abrahamson et&#x20;al., 2012</xref>) and a phenylalanine dehydrogenase from <italic>Bacillus badius</italic> (<xref ref-type="bibr" rid="B2">Abrahamson et&#x20;al., 2013</xref>). After altering two determinant residues of carboxylate recognition, the natural AADHs were transformed to AmDHs, thereby eliminating the activity toward ketone acids while affording new activity toward ketones. Taking this advantage, more natural AADHs from diverse organisms have been explored and engineered to AmDHs based on the introduction of two-point mutations, which were then harnessed in the asymmetric production of chiral amines (<xref ref-type="bibr" rid="B4">Au et&#x20;al., 2014</xref>; <xref ref-type="bibr" rid="B7">Chen et&#x20;al., 2015</xref>; <xref ref-type="bibr" rid="B49">Ye et&#x20;al., 2015</xref>; <xref ref-type="bibr" rid="B14">Franklin et&#x20;al., 2020</xref>; <xref ref-type="bibr" rid="B22">Liu et&#x20;al., 2020</xref>). In addition, the engineered AmDHs derived from AADHs were also utilized in the preparation of chiral amino alcohols, which are usually with very high enantioselectivity (&#x3e;99% <italic>ee</italic>), making these enzymes of potential value in biocatalysis (<xref ref-type="bibr" rid="B6">Chen et&#x20;al., 2019</xref>). Our previous work has characterized and engineered five novel AmDHs from natural AADHs by genome mining, these newly identified AmDHs provided reductive amination of a broad range of prochiral &#x3b1;- and &#x3b2;-hydroxy ketones in a high stereoselective manner (<xref ref-type="bibr" rid="B42">Wang et&#x20;al., 2020</xref>). As an example, the engineered AmDH derived from the leucine dehydrogenase from <italic>Sporosarcina psychrophila</italic> (<italic>Sp</italic>AmDH), enabled the reduction of 1-hydroxybutan-2-one (1a) to (<italic>S</italic>)-2-aminobutan-1-ol ((<italic>S</italic>)-1b, <xref ref-type="scheme" rid="sch1">Scheme 1</xref>) with &#x3e;99% selectivity, while the conversion is modest (&#x223c;60%) at a substrate concentration of 50&#xa0;mM (<xref ref-type="bibr" rid="B42">Wang et&#x20;al., 2020</xref>).</p>
<fig id="sch1">
<label>SCHEME 1</label>
<caption>
<p>
<italic>Sp</italic>AmDH-catalyzed asymmetric reductive amination of 1a to (<italic>S</italic>)-1b by using ammonia as the sole amino donor, and glucose dehydrogenase (GDH) cell-free extract (CFE) for NADH cofactor regeneration.</p>
</caption>
<graphic xlink:href="fbioe-09-778584-g007.tif"/>
</fig>
<p>In this work, we sought to optimize the activity of <italic>Sp</italic>AmDH in the biosynthesis of (<italic>S</italic>)-1b, which is an important intermediate desired in the preparation of antitubercular drugs ethambutol (<xref ref-type="bibr" rid="B28">Pablos-M&#xe9;ndez et&#x20;al., 1998</xref>; <xref ref-type="sec" rid="s10">Supplementary Scheme S1</xref>). When aiming at the improvement of activity and/or selectivity, the combinatorial active-site saturation test (CAST) combined with iterative saturation mutagenesis (ISM) has been emerged as a powerful means in protein engineering (<xref ref-type="bibr" rid="B34">Reetz et&#x20;al., 2005</xref>; <xref ref-type="bibr" rid="B48">Yanai et&#x20;al., 2013</xref>; <xref ref-type="bibr" rid="B31">Qu et&#x20;al., 2020</xref>; <xref ref-type="bibr" rid="B20">Li D. et&#x20;al., 2021</xref>; <xref ref-type="bibr" rid="B21">Li J.&#x20;et&#x20;al., 2021</xref>; <xref ref-type="bibr" rid="B33">Qu et&#x20;al., 2021</xref>; <xref ref-type="bibr" rid="B51">Zheng et&#x20;al., 2021</xref>). Taking the advantage of CAST/ISM, three robust variants of <italic>Sp</italic>AmDH with improved activity and high stereoselectivity were obtained, and their potential as biocatalysts in the preparative scale reactions was explored. Computational docking simulations were also performed to rationalize the elevated activity of <italic>Sp</italic>AmDH variants.</p>
</sec>
<sec sec-type="materials|methods" id="s2">
<title>Materials and Methods</title>
<sec id="s2-1">
<title>Chemicals and Reagents</title>
<p>Hydroxy ketones, chiral amino alcohols, and other chemical reagents were purchased from Bidepharm (Shanghai, China), Energy Chemical (Shanghai, China), Kaiwei Chemical (Shanghai, China), Acmec (Shanghai, China), Arkpharm (Chicago, United&#x20;States), Accela (Shanghai, China), Aladdin (Shanghai, China), Macklin (Shanghai, China), Heowns (Tianjin, China), and CINC (Shanghai, China). PrimeSTAR DNA polymerase and restriction enzyme Dpn I were ordered from TAKARA and NEB, respectively. The primer synthesis and sequencing were carried out by GENEWIZ. A plasmid preparation kit was purchased from TIANGEN Biotech. All other chemical reagents can be obtained through commercialization, unless otherwise&#x20;noted.</p>
</sec>
<sec id="s2-2">
<title>Site-Directed Mutagenesis</title>
<p>Mutagenesis was constructed by using the overlap PCR and megaprimer approach (<xref ref-type="bibr" rid="B41">Tyagi et&#x20;al., 2004</xref>) with high-fidelity master mix polymerase. Reaction mixtures (50&#xa0;&#x3bc;l) typically contained ddH<sub>2</sub>O (22&#xa0;&#x3bc;l), 2&#xd7; high-fidelity master mix polymerase (25&#xa0;&#x3bc;l), template DNA (1&#xa0;&#x3bc;l, 50&#xa0;ng), forward primer (1&#xa0;&#x3bc;l, 0.2&#xa0;&#x3bc;M), and reverse primer (1&#xa0;&#x3bc;l, 0.2&#xa0;&#x3bc;M). The PCR conditions for short fragment were as follows: 98&#xb0;C, 2&#xa0;min (98&#xb0;C, 10&#xa0;s; 55&#xb0;C, 15&#xa0;s; 72&#xb0;C, 30&#xa0;s) 30 cycles; 72&#xb0;C, 3&#xa0;min. For mega-PCR (<xref ref-type="bibr" rid="B41">Tyagi et&#x20;al., 2004</xref>), 1st PCR product (2&#xa0;&#x3bc;l, 800&#xa0;ng) was used as primer, and the PCR conditions as below: 98&#xb0;C, 2&#xa0;min (98&#xb0;C, 10&#xa0;s; 60&#xb0;C, 15&#xa0;s; 72&#xb0;C, 3.5&#xa0;min) 30 cycles, 72&#xb0;C, 5&#xa0;min. The PCR products were treated with restriction endonuclease Dpn I for 3&#xa0;h and then electroporated into <italic>E.&#x20;coli</italic> BL21 (DE3). After culturing for 12 h, the colonies on the plate were washed with ddH<sub>2</sub>O, and the plasmids were extracted and sequenced. The primers used for constructing single-site saturation mutagenesis and combinatory saturation libraries were listed in <xref ref-type="sec" rid="s10">Supplementary Tables S1, S2</xref>, respectively.</p>
</sec>
<sec id="s2-3">
<title>Screening of Saturation Mutagenesis Libraries</title>
<p>Clones from the plate were transferred to 96-well deep-well culture plates containing 300&#xa0;&#x3bc;l of LB medium (50&#xa0;&#x3bc;g/ml kanamycin), shaking at 37&#xb0;C and 800&#xa0;rpm for 10&#xa0;h. Then 120&#x20;&#x3bc;l of the aforementioned culture broth was transferred to a 96-well glycerol plate, 60&#xa0;&#x3bc;l of glycerol (60%, v/v) was added, and stored at &#x2212;80&#xb0;C. At the same time, 800&#xa0;&#x3bc;l of the TB medium was added to the 96-well deep-well culture plates, IPTG (0.2&#xa0;mM) and kanamycin (50&#xa0;&#x3bc;g/ml) were added, and the culture was shaken at 30&#xb0;C, 800&#xa0;rpm for 12&#xa0;h for protein expression. The cells were collected by centrifugation at 4,000&#xa0;rpm, 4&#xb0;C for 10&#xa0;min. The cells were washed and resuspended with 400&#xa0;&#x3bc;l of potassium phosphate buffer (PBK, 50&#xa0;mM, pH 7.4). DNase I (6&#xa0;U/ml) and lysozyme (1&#xa0;mg/ml) were added to the culture and were shaken at 30&#xb0;C for 1&#xa0;h to lysis cells. After low-temperature centrifugation (4&#xb0;C, 4,000&#xa0;rpm, for 30&#xa0;min), the supernatant was used for enzyme activity determination. The reductive amination reaction was performed in NH<sub>4</sub>Cl/NH<sub>3</sub>&#xb7;H<sub>2</sub>O buffer (1&#xa0;M, pH 8.5) containing 200&#xa0;&#x3bc;l supernatant, 10&#xa0;mM substrate 1a, 1&#xa0;mM NAD<sup>&#x2b;</sup>, 100&#xa0;mM glucose, and 2&#xa0;mg/ml GDH at 30&#xb0;C, 800&#xa0;rpm for 24&#xa0;h. After that, 1&#x20;&#x3bc;l of 1M para-methoxy-2-amino benzamidoxime (PMA) was added to 99&#xa0;&#x3bc;l of the reaction solution, and fluorescence was measured using an excitation wavelength of 380&#xa0;nm and emission wavelength of 520&#xa0;nm for substrate consumption (<xref ref-type="bibr" rid="B26">Mei et&#x20;al., 2020</xref>).</p>
</sec>
<sec id="s2-4">
<title>Active Assay</title>
<p>For single point saturation mutation library rescreening, the best clones from 96-well glycerol plates were cultivated, expressed in a shake flask and used for biotransformation. Reductive amination reactions were performed in a reaction mixture (0.5&#xa0;ml) containing 1&#xa0;M NH<sub>4</sub>Cl/NH<sub>3</sub>&#xb7;H<sub>2</sub>O buffer (pH 8.5), 1&#xa0;mM NAD<sup>&#x2b;</sup>, 100&#xa0;mM glucose, 2&#xa0;mg/ml GDH cell-free extract (CFE), 6&#xa0;U/ml DNase I, 20&#xa0;mM 1a, and 20&#xa0;mg/ml mutant CFE in 2&#xa0;ml Eppendorf tubes at 30&#xb0;C, 1,000&#xa0;rpm for 24&#xa0;h in a thermostatic metal bath. For the combinatorial saturation mutation library screening, using the same procedure as before, except for that, the concentration of 1a and the wet cell of mutant were 40&#xa0;mM and 0.1&#xa0;g/ml, respectively. After the reaction was over, the aforementioned reaction solution was boiled for 5&#xa0;min and then centrifuged at 12,000&#xa0;rpm for 10&#xa0;min to remove the precipitate. The supernatant was measured by HPLC to detect the conversion of 1a. The conversions of hydroxy ketones substrates (1a&#x2013;8a) to chiral amino alcohol products (1b-8b) were measured with Marfey&#x2019;s reagent (1-fluoro-2, 4-dinitrophenyl-5-L-alanine amide) for pre-column derivatization. The reaction mixture was mixed with 100&#xa0;&#x3bc;l sample, 30&#xa0;&#x3bc;l of Marfey&#x2019;s reagent (14&#xa0;mM), 80&#xa0;&#x3bc;l NaHCO<sub>3</sub> (1&#xa0;M), and 200&#xa0;&#x3bc;l DMSO at 80&#xb0;C, 1,000&#xa0;rpm for 10&#xa0;min. Finally, 10&#xa0;&#x3bc;l HCl (4&#xa0;M) was added to stop the reaction. Detection conditions were given as follows: Zorbax SB-C18 column (4.6 &#xd7; 150&#xa0;mm, 5&#xa0;&#x3bc;m), detection wavelength: 340&#xa0;nm, temperature: 25&#xb0;C, flow rate: 1&#xa0;ml/min, loading volume: 10&#xa0;&#x3bc;l, mobile phase buffer A: ddH<sub>2</sub>O (0.1% trifluoroacetic acid), buffer B: methanol (0.1% trifluoroacetic acid), gradient program: 40% B, hold for 6&#xa0;min, increase B to 60% in 9&#xa0;min, hold for 3&#xa0;min, decrease B to 40% in 2&#xa0;min, and hold for 5&#xa0;min. More details are listed in <xref ref-type="sec" rid="s10">Supplementary Table&#x20;S3</xref>.</p>
</sec>
<sec id="s2-5">
<title>Protein Expression and Purification</title>
<p>
<italic>E.&#x20;coli</italic> BL21(DE3) glycerol bacteria containing <italic>Sp</italic>AmDH gene were cultivated in 5&#xa0;ml LB liquid medium (50&#xa0;&#x3bc;g/ml kanamycin) for 10&#xa0;h. The previous culture was transferred to the TB medium (100&#xa0;ml) (50&#xa0;&#x3bc;g/ml kanamycin) and was cultured at 37&#xb0;C, 220&#xa0;rpm. The culture was induced by the addition of IPTG (0.1&#xa0;mM) when OD<sub>600</sub> reached 0.8 and was then allowed to grow for an additional 12&#xa0;h at 20&#xb0;C. The cells expressing AmDHs were harvested, sonicated, and centrifuged (4&#xb0;C, 12,000&#xa0;rpm) for 60&#xa0;min to remove the precipitate. The supernatant with soluble His-tagged protein was filtered using a 0.45-&#xb5;m filter membrane and was verified by SDS-PAGE analysis (<xref ref-type="sec" rid="s10">Supplementary Figure S1</xref>). The column (HisTrap FF, 5&#xa0;ml) was washed with A buffer (50&#xa0;mM PBK containing 300&#xa0;mM NaCl and 20&#xa0;mM imidazole, pH 8.0) before and after the supernatant was loaded. The proteins were eluted with B buffer containing a high concentration of salt (50&#xa0;mM PBK containing 300&#xa0;mM NaCl and 500&#xa0;mM imidazole, pH 8.0). The eluates were ultrafiltered (4&#xb0;C, 3,500&#xa0;rpm) with an ultrafiltration tube (10,000&#xa0;Da) to concentrate and replace the buffer (25&#xa0;mM PBK, 100&#xa0;mM NaCl, 5% glycerol, pH 8.0). The protein concentration was confirmed by measuring the absorbance at 280&#xa0;nm using a Nano-300 micro-spectrophotometer.</p>
</sec>
<sec id="s2-6">
<title>Total Turnover Numbers Assay for Conversion of Substrate 1a to 1b Using <italic>Sp</italic>AmDH Variants</title>
<p>The asymmetric reductive amination reactions were performed with 0.32&#x2013;0.64&#xa0;mg/ml purified enzyme, 1&#xa0;M NH<sub>4</sub>Cl/NH<sub>3</sub>&#xb7;H<sub>2</sub>O buffer (pH 8.5), 1&#xa0;mM NAD<sup>&#x2b;</sup>, 100&#xa0;mM glucose, 2&#xa0;mg/ml GDH CFE, and 40&#xa0;mM 1a. The reaction mixture was proceeded at 30&#xb0;C, 1,000&#xa0;rpm for 24&#xa0;h. The product was then detected by HPLC. TTN was defined as the molar number of the product yield divided by the catalyst concentration (<xref ref-type="bibr" rid="B32">Qu et&#x20;al., 2019</xref>).</p>
</sec>
<sec id="s2-7">
<title>Determination of Kinetic Parameters and Thermostability</title>
<p>The kinetic parameters were obtained by measuring the initial velocities of NADH consumption (the initial rate of change in absorbance at 340&#xa0;nm) in the enzymatic reaction and fitting the curve according to the Michaelis&#x2013;Menten equation (<xref ref-type="sec" rid="s10">Supplementary Figure S2</xref>). The activity assay was performed in a mixture containing 0.2&#xa0;mM NADH, 1&#x2013;30&#xa0;mM 1-hydroxy-2-butanone, 1&#xa0;M NH<sub>4</sub>Cl/NH<sub>3</sub>&#xb7;H<sub>2</sub>O (pH 8.5), and the purified enzyme (1&#xa0;mg/ml). The reaction was initiated by the addition of the enzyme and was monitored for 5&#xa0;min at 30&#xb0;C. The activity was determined by measuring NADH oxidation from a decrease in the absorbance at 340&#xa0;nm (&#x3b5; &#x3d; 6,220&#xa0;M<sup>&#x2212;1</sup>&#xa0;cm<sup>&#x2212;1</sup>) and then Origin was used to perform the nonlinear fitting of the Michaelis&#x2013;Menten equation. One unit (1&#xa0;U) of activity is defined as the amount of enzyme required to consume 1&#xa0;&#x3bc;M NADH in 1&#xa0;minute. For thermostability, 1&#xa0;mg/ml pure enzyme solution was incubated at different temperatures (30&#x2013;70&#xb0;C) for 15&#xa0;min, followed by measuring the residual activity in 1&#xa0;M NH<sub>4</sub>Cl/NH<sub>3</sub>&#xb7;H<sub>2</sub>O (pH 8.5) containing 0.2&#xa0;mM NADH, 10&#xa0;mM substrate 1a at 50&#xb0;C for 2&#xa0;min. All experiments were conducted in triplicate.</p>
</sec>
<sec id="s2-8">
<title>Preparative-Scale Reactions Using <italic>Sp</italic>AmDH Mutants</title>
<p>The <italic>Sp</italic>AmDH mutants wh18 and wh84 were inoculated in the 5&#xa0;ml LB medium (50&#xa0;&#x3bc;g/ml kanamycin) for 10&#xa0;h (37&#xb0;C, 220&#xa0;rpm). The aforementioned culture was inoculated into the 1,000&#xa0;ml TB medium (50&#xa0;&#x3bc;g/ml kanamycin) and cultured at 37&#xb0;C, 220&#xa0;rpm until the OD<sub>600</sub> reached 0.8&#x2013;0.9. IPTG was then added to a final concentration of 0.1&#xa0;mM, and the culture was allowed to grow for additional 16&#xa0;h at 20&#xb0;C, 220&#xa0;rpm. The cells were pelleted by centrifugation for 20&#xa0;min (4&#xb0;C, 4,000&#xa0;rpm) and washed once with phosphate buffer (50&#xa0;mM, pH 7.4). Subsequently, 0.1&#xa0;g/ml wet cells, 1&#xa0;M NH<sub>4</sub>Cl/NH<sub>3</sub>&#xb7;H<sub>2</sub>O buffer (pH 8.5), 1&#xa0;mM NAD<sup>&#x2b;</sup>, 100&#xa0;mM glucose, 2&#xa0;mg/ml GDH CFE, 6&#xa0;U/ml DNase I, 1&#xa0;mg/ml lysozyme, and 1a (100, 200&#xa0;mM) were mixed for 10&#xa0;ml in a Erlenmeyer flask. The reaction was performed at 30&#xb0;C, 220&#xa0;rpm for 24&#xa0;h in a shaker with triple replica. Then 200&#x20;&#x3bc;l samples were taken at 0, 1, 2, 3, 4, 8, 12, 18, and 24&#xa0;h and then prepared and analyzed by HPLC. The 100&#xa0;mM scaled-up reaction of 1a catalyzed by wh84 was terminated by adding 5% H<sub>2</sub>SO<sub>4</sub> to pH &#x3c;2 and then centrifuged at an rpm of 4,000 for 20&#xa0;min at 4&#xb0;C, to collect the supernatant. The product ((<italic>S</italic>)-2a) was purified via an ion exchange method with Dowex&#xae; 50WX8 ion exchange resin (<xref ref-type="bibr" rid="B7">Chen et&#x20;al., 2015</xref>). The column was prepared by washing with 100&#xa0;ml ddH<sub>2</sub>O and 50&#xa0;ml 5% w/v H<sub>2</sub>SO<sub>4</sub>. Then, the acidified reaction supernatant was loaded into the column at a low flow rate, washed with ddH<sub>2</sub>O until pH &#x223c;7.0, eluted with 9% w/v NH<sub>4</sub>OH (100&#xa0;ml), and dried via rotary evaporation to harvest the final product (<italic>S</italic>)-2a. <sup>1</sup>H NMR (400&#xa0;MHz, D<sub>2</sub>O) &#x3b4; 3.61 (dd, <italic>J</italic>&#x20;&#x3d; 11.8, 4.1 Hz, 1H), 3.51&#x2013;3.33 (m 1H), 3.06&#x2013;2.82 (m, 1H), 1.57&#x2013;1.33 (m, 2H), and 0.98&#x2013;0.81 (m,&#x20;3H).</p>
</sec>
<sec id="s2-9">
<title>Model Generation and Substrate Docking</title>
<p>The structure of the mutant wh84 (K68S/N261L/I111F/V294C/E114V) was generated by PyMol program (<ext-link ext-link-type="uri" xlink:href="http://www.pymol.org">http://www.pymol.org</ext-link>) using the crystallographic structure of <italic>Sp</italic>LeuDH (PDB ID: 3VPX, <xref ref-type="bibr" rid="B50">Zhao et&#x20;al., 2012</xref>) as a template. The initial structure of wh84 was relaxed/repacked before docking using Rosetta relax program (<xref ref-type="bibr" rid="B11">Conway et&#x20;al., 2014</xref>). The generated pose with the lowest Rosetta_total_score was selected as input file for docking. The cofactor NADH, substrate 1a, and NH<sub>4</sub>
<sup>&#x2b;</sup> were prepared in Schr&#xf6;dinger Maestro software (<xref ref-type="bibr" rid="B37">Schr&#xf6;dinger, 2015</xref>). Thereafter, NADH and 1a were stepwise docked into the active site of wh84 by using Rosetta docking program (<xref ref-type="bibr" rid="B10">Combs et&#x20;al., 2013</xref>). Thereafter, 1a was docked to the protein&#x2013;NADH complex using the same procedure as NADH, only by replacing the input files. After that, NH<sub>4</sub>
<sup>&#x2b;</sup> was docked to the protein&#x2013;NADH-1a complex by using AutoDock Vina (<xref ref-type="bibr" rid="B40">Trott and Olson, 2010</xref>). For docking NH<sub>4</sub>
<sup>&#x2b;</sup>, a total of 16 poses were generated by Vina, and only the pose with proper interactions with D115 and 1a was&#x20;kept.</p>
</sec>
</sec>
<sec sec-type="results|discussion" id="s3">
<title>Results and Discussion</title>
<sec id="s3-1">
<title>Knowledge-Based and Structural Guided Engineering of SpLeuDH</title>
<p>Wild-type (WT) leucine dehydrogenase from <italic>Sporosarcina psychrophila</italic> (<italic>Sp</italic>LeuDH, Accession No.: WP_067209859) has been successfully engineered to an amine dehydrogenase (<italic>Sp</italic>AmDH) by implanting the double mutations K68S/N261L in our recent work (<xref ref-type="bibr" rid="B42">Wang et&#x20;al., 2020</xref>). Based on the crystallographic structure of <italic>Sp</italic>LeuDH (PDB ID: 3VPX, <xref ref-type="bibr" rid="B50">Zhao et&#x20;al., 2012</xref>), this <italic>Sp</italic>AmDH variant (K68S/N261L, dubbed wh18) showed excellent stereoselectivity (&#x3e;99% ee) in the transformation of 1a to 1b, while the catalytic efficiency was modest when it was applied in large-scale production (<xref ref-type="bibr" rid="B42">Wang et&#x20;al., 2020</xref>). Thus, the CAST/ISM strategy was employed with the aim of enhancing the activity of <italic>Sp</italic>AmDH. To identify the hot spot positions that may manipulate the activity, the beneficial mutations reported in other engineering studies toward AmDHs were collected (<xref ref-type="table" rid="T1">Table&#x20;1</xref>). We anticipated that targeting these residues at the equivalent positions in <italic>Sp</italic>AmDH may give rise to more proficient variants. Moreover, three additional positions L61, L239, and A295 were also selected as they are situated at the substrate binding pocket (<xref ref-type="table" rid="T1">Table&#x20;1</xref>; <xref ref-type="fig" rid="F1">Figure&#x20;1</xref>).</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>Key residues selected for engineering <italic>Sp</italic>AmDH based on published&#x20;data.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th rowspan="2" align="left">Entry</th>
<th rowspan="2" align="center">
<italic>Sp</italic>AmDH site</th>
<th colspan="3" align="center">Data collection</th>
<th rowspan="2" align="center">References</th>
</tr>
<tr>
<th align="center">Beneficial position</th>
<th align="center">Enzyme</th>
<th align="center">Comment</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">1</td>
<td align="center">L40</td>
<td align="center">L40</td>
<td align="left">
<italic>Bs</italic>LeuDH</td>
<td align="left">Lining the binding pocket</td>
<td align="left">
<xref ref-type="bibr" rid="B1">Abrahamson et&#x20;al. (2012)</xref>
</td>
</tr>
<tr>
<td align="left">2</td>
<td align="center">G41</td>
<td align="center">G41</td>
<td align="left">
<italic>Bs</italic>LeuDH</td>
<td align="left">Lining the binding pocket</td>
<td align="left">
<xref ref-type="bibr" rid="B1">Abrahamson et&#x20;al. (2012)</xref>
</td>
</tr>
<tr>
<td align="left">3</td>
<td align="center">G42</td>
<td align="center">G42</td>
<td align="left">
<italic>Bs</italic>LeuDH</td>
<td align="left">Lining the binding pocket</td>
<td align="left">
<xref ref-type="bibr" rid="B1">Abrahamson et&#x20;al. (2012)</xref>
</td>
</tr>
<tr>
<td align="left">4</td>
<td align="center">T43</td>
<td align="center">T41</td>
<td align="left">
<italic>Rs</italic>PheDH</td>
<td align="left">Within 6&#xc5; from the substrate</td>
<td align="left">
<xref ref-type="bibr" rid="B49">Ye et&#x20;al. (2015)</xref>
</td>
</tr>
<tr>
<td align="left">5</td>
<td align="center">M65</td>
<td align="center">M65</td>
<td align="left">
<italic>Bs</italic>LeuDH</td>
<td align="left">Lining the binding pocket</td>
<td align="left">
<xref ref-type="bibr" rid="B1">Abrahamson et&#x20;al. (2012)</xref>
</td>
</tr>
<tr>
<td align="left">6</td>
<td align="center">K68</td>
<td align="center">K66</td>
<td align="left">
<italic>Rs</italic>PheDH</td>
<td align="left">Carboxylate recognition</td>
<td align="left">
<xref ref-type="bibr" rid="B49">Ye et&#x20;al. (2015)</xref>
</td>
</tr>
<tr>
<td align="left">7</td>
<td align="center">K68</td>
<td align="center">K68</td>
<td align="left">
<italic>Lf</italic>LeuDH</td>
<td align="left">Altering the substrate specificity</td>
<td align="left">
<xref ref-type="bibr" rid="B6">Chen et&#x20;al. (2019)</xref>
</td>
</tr>
<tr>
<td align="left">8</td>
<td align="center">N69</td>
<td align="center">M67</td>
<td align="left">
<italic>Rs</italic>PheDH</td>
<td align="left">Within 6&#xc5; from substrate</td>
<td align="left">
<xref ref-type="bibr" rid="B49">Ye et&#x20;al. (2015)</xref>
</td>
</tr>
<tr>
<td align="left">9</td>
<td align="center">I111</td>
<td align="center">W114</td>
<td align="left">
<italic>Rs</italic>PheDH</td>
<td align="left">Within 6&#xc5; from substrate</td>
<td align="left">
<xref ref-type="bibr" rid="B49">Ye et&#x20;al. (2015)</xref>
</td>
</tr>
<tr>
<td align="left">10</td>
<td align="center">T112</td>
<td align="center">T115</td>
<td align="left">
<italic>Rs</italic>PheDH</td>
<td align="left">Within 6&#xc5; from substrate</td>
<td align="left">
<xref ref-type="bibr" rid="B49">Ye et&#x20;al. (2015)</xref>
</td>
</tr>
<tr>
<td align="left">11</td>
<td align="center">A113</td>
<td align="center">A113</td>
<td align="left">
<italic>Bs</italic>LeuDH</td>
<td align="left">Altering the substrate specificity</td>
<td align="left">
<xref ref-type="bibr" rid="B1">Abrahamson et&#x20;al. (2012)</xref>
</td>
</tr>
<tr>
<td align="left">12</td>
<td align="center">A113</td>
<td align="center">A113</td>
<td align="left">
<italic>Lf</italic>LeuDH</td>
<td align="left">Enlarging the active-site</td>
<td align="left">
<xref ref-type="bibr" rid="B6">Chen et&#x20;al. (2019)</xref>
</td>
</tr>
<tr>
<td align="left">13</td>
<td align="center">E114</td>
<td align="center">E114</td>
<td align="left">
<italic>Bs</italic>LeuDH</td>
<td align="left">Altering the substrate specificity</td>
<td align="left">
<xref ref-type="bibr" rid="B1">Abrahamson et&#x20;al. (2012)</xref>
</td>
</tr>
<tr>
<td align="left">14</td>
<td align="center">D115</td>
<td align="center">D115</td>
<td align="left">
<italic>Bs</italic>LeuDH</td>
<td align="left">Essential to the catalytic mechanism</td>
<td align="left">
<xref ref-type="bibr" rid="B1">Abrahamson et&#x20;al. (2012)</xref>
</td>
</tr>
<tr>
<td align="left">15</td>
<td align="center">V116</td>
<td align="center">V116</td>
<td align="left">
<italic>Bs</italic>LeuDH</td>
<td align="left">Altering the substrate specificity</td>
<td align="left">
<xref ref-type="bibr" rid="B1">Abrahamson et&#x20;al. (2012)</xref>
</td>
</tr>
<tr>
<td align="left">16</td>
<td align="center">T134</td>
<td align="center">T134</td>
<td align="left">
<italic>Lf</italic>LeuDH</td>
<td align="left">Enlarging the active-site</td>
<td align="left">
<xref ref-type="bibr" rid="B6">Chen et&#x20;al. (2019)</xref>
</td>
</tr>
<tr>
<td align="left">17</td>
<td align="center">P146</td>
<td align="center">S149</td>
<td align="left">
<italic>Rs</italic>PheDH</td>
<td align="left">Within 6&#xc5; from substrate</td>
<td align="left">
<xref ref-type="bibr" rid="B49">Ye et&#x20;al. (2015)</xref>
</td>
</tr>
<tr>
<td align="left">18</td>
<td align="center">T150</td>
<td align="center">T153</td>
<td align="left">
<italic>Rs</italic>PheDH</td>
<td align="left">Within 6&#xc5; from substrate</td>
<td align="left">
<xref ref-type="bibr" rid="B49">Ye et&#x20;al. (2015)</xref>
</td>
</tr>
<tr>
<td align="left">19</td>
<td align="center">A187</td>
<td align="center">A187</td>
<td align="left">
<italic>Bs</italic>LeuDH</td>
<td align="left">Altering the substrate specificity</td>
<td align="left">
<xref ref-type="bibr" rid="B1">Abrahamson et&#x20;al. (2012)</xref>
</td>
</tr>
<tr>
<td align="left">20</td>
<td align="center">N261</td>
<td align="center">N261</td>
<td align="left">
<italic>Lf</italic>LeuDH</td>
<td align="left">Responsible for altering the substrate specificity</td>
<td align="left">
<xref ref-type="bibr" rid="B6">Chen et&#x20;al. (2019)</xref>
</td>
</tr>
<tr>
<td align="left">21</td>
<td align="center">N262</td>
<td align="center">N262</td>
<td align="left">
<italic>Rs</italic>PheDH</td>
<td align="left">Interact with the carboxyl group of the natural substrate</td>
<td align="left">
<xref ref-type="bibr" rid="B49">Ye et&#x20;al. (2015)</xref>
</td>
</tr>
<tr>
<td align="left">22</td>
<td align="center">N287</td>
<td align="center">N288</td>
<td align="left">
<italic>Rs</italic>PheDH</td>
<td align="left">Within 6&#xc5; from substrate</td>
<td align="left">
<xref ref-type="bibr" rid="B49">Ye et&#x20;al. (2015)</xref>
</td>
</tr>
<tr>
<td align="left">23</td>
<td align="center">S288</td>
<td align="center">A289</td>
<td align="left">
<italic>Rs</italic>PheDH</td>
<td align="left">Within 6&#xc5; from substrate</td>
<td align="left">
<xref ref-type="bibr" rid="B49">Ye et&#x20;al. (2015)</xref>
</td>
</tr>
<tr>
<td align="left">24</td>
<td align="center">G290</td>
<td align="center">G291</td>
<td align="left">
<italic>Rs</italic>PheDH</td>
<td align="left">Within 6&#xc5; from substrate</td>
<td align="left">
<xref ref-type="bibr" rid="B49">Ye et&#x20;al. (2015)</xref>
</td>
</tr>
<tr>
<td align="left">25</td>
<td align="center">V291</td>
<td align="center">V291</td>
<td align="left">
<italic>Bs</italic>LeuDH</td>
<td align="left">Lining the binding pocket</td>
<td align="left">
<xref ref-type="bibr" rid="B1">Abrahamson et&#x20;al. (2012)</xref>
</td>
</tr>
<tr>
<td align="left">26</td>
<td align="center">I292</td>
<td align="center">I292</td>
<td align="left">
<italic>Bs</italic>LeuDH</td>
<td align="left">Altering the substrate specificity</td>
<td align="left">
<xref ref-type="bibr" rid="B1">Abrahamson et&#x20;al. (2012)</xref>
</td>
</tr>
<tr>
<td align="left">27</td>
<td align="center">V294</td>
<td align="center">V294</td>
<td align="left">
<italic>Bs</italic>LeuDH</td>
<td align="left">Lining the binding pocket</td>
<td align="left">
<xref ref-type="bibr" rid="B1">Abrahamson et&#x20;al. (2012)</xref>
</td>
</tr>
<tr>
<td align="left">28</td>
<td align="center">E297</td>
<td align="center">E297</td>
<td align="left">
<italic>Bs</italic>LeuDH</td>
<td align="left">Changing the substrate specificity</td>
<td align="left">
<xref ref-type="bibr" rid="B1">Abrahamson et&#x20;al. (2012)</xref>
</td>
</tr>
<tr>
<td align="left">29</td>
<td align="center">L61</td>
<td align="center">&#x2014;</td>
<td align="left">&#x2014;</td>
<td align="left">Lining the binding pocket</td>
<td align="left">This study</td>
</tr>
<tr>
<td align="left">30</td>
<td align="center">L239</td>
<td align="center">&#x2014;</td>
<td align="left">&#x2014;</td>
<td align="left">Lining the binding pocket</td>
<td align="left">This study</td>
</tr>
<tr>
<td align="left">31</td>
<td align="center">A295</td>
<td align="center">&#x2014;</td>
<td align="left">&#x2014;</td>
<td align="left">Lining the binding pocket</td>
<td align="left">This study</td>
</tr>
</tbody>
</table>
</table-wrap>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Residues lining the substrate-binding pocket of <italic>Sp</italic>LeuDH (PDB ID: 3VPX). The sites marked in green, cyan, and blue are obtained from the three studies <xref ref-type="bibr" rid="B1">Abrahamson et&#x20;al. (2012</xref>); <xref ref-type="bibr" rid="B49">Ye et&#x20;al. (2015</xref>); <xref ref-type="bibr" rid="B6">Chen et&#x20;al. (2019</xref>), respectively. The sites marked in magenta are found in this study.</p>
</caption>
<graphic xlink:href="fbioe-09-778584-g001.tif"/>
</fig>
<p>The 27 positions were then performed site-directed saturation mutagenesis using wh18 as the template, each site was substituted by the other 19 amino acids with NNK codon degeneracy (32 codons). To satisfy the 95% library coverage, 96 clones were screened for each position by using <italic>para</italic>-methoxy-2-amino benzamidoxime (PMA) as colorimetric probe (<xref ref-type="bibr" rid="B26">Mei et&#x20;al., 2020</xref>). After the initial assaying, the improved variants (hits) were then picked up for further evaluation using the reaction conditions shown in <xref ref-type="scheme" rid="sch1">Scheme 1</xref>. As a result, several active variants showing pronounced degrees of conversion for substrate 1a were obtained (<xref ref-type="fig" rid="F2">Figure&#x20;2</xref>). Five of them including wh27, wh43, wh50, wh53, and wh59 showed more than 10% increment on the formation of (<italic>S</italic>)-1b compared to the starting enzyme wh18 (<xref ref-type="fig" rid="F2">Figure&#x20;2</xref>).</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Improved variants obtained by screening the single point saturation mutagenesis libraries on the 27 positions. Reductive amination reactions were performed in a reaction mixture (0.5&#xa0;ml) containing 1&#xa0;M NH<sub>4</sub>Cl/NH<sub>3</sub>&#xb7;H<sub>2</sub>O buffer (pH 8.5), 1&#xa0;mM NAD<sup>&#x2b;</sup>, 100&#xa0;mM glucose, 2&#xa0;mg/ml GDH cell-free extract (CFE), 6&#xa0;U/ml DNase I, 20&#xa0;mM 1a, and 20&#xa0;mg/ml mutant CFE at 30&#xb0;C, 1,000&#xa0;rpm for 24&#xa0;h. The conversion was detected by HPLC at least three&#x20;times.</p>
</caption>
<graphic xlink:href="fbioe-09-778584-g002.tif"/>
</fig>
</sec>
<sec id="s3-2">
<title>Combinatorial Engineering of SpAmDH Using Reduced Amino Acid Alphabets</title>
<p>After purification, the five variants were then assayed for the specific activity, three of which including wh27, wh50, and wh53 displayed a higher specific activity than that of wh18 (<xref ref-type="table" rid="T2">Table&#x20;2</xref>). In order to investigate the potential epistatic interactions operating between the individual point mutations shown in <xref ref-type="table" rid="T2">Table&#x20;2</xref>, ten additional double mutants (wh61&#x2013;wh70, <xref ref-type="sec" rid="s10">Supplementary Table S4</xref>) were constructed and tested using the whole-cell lysate system. As a result, the variant wh43 showed the highest conversion of 85%, while none of the ten combinatorial mutants can exceed the conversion of 80%. It suggests that no additive effects among the five single mutations I111F, T134F, L239F, V291C, and A295T were in pairs, and the triple to quintuple mutants were therefore not constructed further.</p>
<table-wrap id="T2" position="float">
<label>TABLE 2</label>
<caption>
<p>Specific activity of <italic>Sp</italic>AmDH mutants toward substrate&#x20;1a.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Code</th>
<th align="center">Mutants</th>
<th align="center">Specific activity (U/mg)<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">wh18</td>
<td align="center">K68S/N261L</td>
<td align="char" char="plusmn .">0.118&#x20;&#xb1; 0.005</td>
</tr>
<tr>
<td align="left">wh27</td>
<td align="center">K68S/N261L/I111F</td>
<td align="char" char="plusmn .">0.177&#x20;&#xb1; 0.03</td>
</tr>
<tr>
<td align="left">wh43</td>
<td align="center">K68S/N261L/T134F</td>
<td align="char" char="plusmn .">0.07&#x20;&#xb1; 0.005</td>
</tr>
<tr>
<td align="left">wh50</td>
<td align="center">K68S/N261L/L239F</td>
<td align="char" char="plusmn .">0.15&#x20;&#xb1; 0.017</td>
</tr>
<tr>
<td align="left">wh53</td>
<td align="center">K68S/N261L/V291C</td>
<td align="char" char="plusmn .">0.167&#x20;&#xb1; 0.005</td>
</tr>
<tr>
<td align="left">wh59</td>
<td align="center">K68S/N261L/A295T</td>
<td align="char" char="plusmn .">0.054&#x20;&#xb1; 0.007</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="Tfn1">
<label>a</label>
<p>Reaction was performed in 1&#xa0;M NH<sub>4</sub>Cl/NH<sub>3</sub>&#xb7;H<sub>2</sub>O buffer (pH 8.5) containing 0.2&#xa0;mM NADH, 1&#xa0;mg/ml purified enzyme and 10&#xa0;mM substrate 1a, at 30&#xb0;C for 5&#xa0;min.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>In parallel, we noted that the three mutants with improved activity, shown in <xref ref-type="table" rid="T2">Table&#x20;2</xref>, are all composed of the substitutions of phenylalanine and cysteine (e.g., I111F, L239F, and V291C), indicating that hydrophobic interaction and steric hindrance may play key roles in tailoring the activity. Therefore, phenylalanine and cysteine were chosen as building blocks for the further saturation mutagenesis to determine the interactions among the positions in adjacent to residues 111, 239, and 291. As such, two focused libraries A and B were constructed using F and C as reduced amino acid alphabets based on the double-code saturation mutagenesis (DCSM) concept (<xref ref-type="bibr" rid="B39">Sun et&#x20;al., 2016</xref>): library A using wh53 as template with residues M65, S68, N69, and S288 involved, while library B applying wh27 as template with residues L40, A113, T134, and V294 arrested. As a result, two improved mutants wh76 (K68S/N261L/V291C/S68C/N69C) and wh81 (K68S/N261L/I111F/V294C) were obtained from libraries A and B, respectively. The variants wh76 and wh81 gave a conversion of 87 and 90% in the transformation of 1a, respectively, with &#x3e;99%&#x20;ee.</p>
</sec>
<sec id="s3-3">
<title>Third Round of Mutagenesis Toward SpAmDH, Characterization, and Preparative-Scale Reduction</title>
<p>The variant wh81 was further used as template for the third round of mutagenesis. In this scenario, an important single mutation E114V was considered because it has been reported that this residue can function on the ammonia activation, and thereby affecting the enzyme activity (<xref ref-type="bibr" rid="B1">Abrahamson et&#x20;al., 2012</xref>; <xref ref-type="bibr" rid="B8">Chen et&#x20;al., 2018</xref>; <xref ref-type="bibr" rid="B29">Patil et&#x20;al., 2018</xref>; <xref ref-type="bibr" rid="B19">Lee et&#x20;al., 2021</xref>). To our delight, the resultant quintuple variant wh84 (K68S/N261L/I111F/V294C/E114V) showed 99% conversion and &#x3e;99% ee toward 1a. Taken together, after three rounds of mutagenesis, the conversion of 1a directed by the <italic>Sp</italic>AmDH mutants was successfully elevated from 46 to 99% (<xref ref-type="sec" rid="s10">Supplementary Figure S3</xref>; <xref ref-type="fig" rid="F3">Figure&#x20;3A</xref>). Thereafter, the best mutants in each round of mutagenesis were then purified and characterized by total turnover numbers (TTN), thermostability, and enzyme kinetics. Likewise, wh27, wh81, and wh84 increased the TTN stepwise for substrate 1a (<xref ref-type="fig" rid="F3">Figure&#x20;3B</xref>). In particular, wh84 increased the TTN up to 32108, which is 3.2-fold in contrast to that of&#x20;wh18.</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Conversion <bold>(A)</bold> and TTN <bold>(B)</bold> analysis of the key variants using 40&#xa0;mM substrate 1a. M1&#x223c;M3 depicted the three rounds of mutagenesis.</p>
</caption>
<graphic xlink:href="fbioe-09-778584-g003.tif"/>
</fig>
<p>To evaluate the enzyme robustness of the engineered variants, thermostability was assessed by measuring <italic>T</italic>
<sub>
<italic>50</italic>
</sub>
<sup>
<italic>15</italic>
</sup>, the temperature at which 50% of the enzyme activity is lost following a heat treatment for 15&#xa0;min. Intriguingly, all of the three variants constructed based on wh18 showed comparable <italic>T</italic>
<sub>
<italic>50</italic>
</sub>
<sup>
<italic>15</italic>
</sup> values, reflecting no trade-off between the thermostability and the improved activity (<xref ref-type="table" rid="T3">Table&#x20;3</xref>). Kinetic studies showed that wh84 has the highest catalytic efficiency (<italic>k</italic>
<sub>cat</sub>/<italic>K</italic>
<sub>m</sub>) (0.346&#x20;s<sup>&#x2212;1</sup>mM<sup>&#x2212;1</sup>) among all the mutants, a more than 3.9-fold increase to the starting template&#x20;wh18.</p>
<table-wrap id="T3" position="float">
<label>TABLE 3</label>
<caption>
<p>Thermostability and kinetic parameters of purified <italic>Sp</italic>AmDH mutants for substrate&#x20;1a.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Code</th>
<th align="center">Thermostabiliy <italic>T</italic>
<sub>
<italic>50</italic>
</sub>
<sup>
<italic>15</italic>
</sup> (&#xb0;C)<xref ref-type="table-fn" rid="Tfn2">
<sup>a</sup>
</xref>
</th>
<th align="center">Mutations</th>
<th align="center">
<italic>K</italic>
<sub>m</sub> (mM)<xref ref-type="table-fn" rid="Tfn3">
<sup>b</sup>
</xref>
</th>
<th align="center">
<italic>k</italic>
<sub>cat</sub> (s<sup>&#x2212;1</sup>)<xref ref-type="table-fn" rid="Tfn3">
<sup>b</sup>
</xref>
</th>
<th align="center">
<italic>k</italic>
<sub>cat</sub>/<italic>K</italic>
<sub>m (</sub>s<sup>&#x2212;1</sup>mM<sup>&#x2212;1</sup>
<sub>)</sub>
<xref ref-type="table-fn" rid="Tfn3">
<sup>b</sup>
</xref>
</th>
<th align="center">Specific activity (U/mg)<xref ref-type="table-fn" rid="Tfn3">
<sup>b</sup>
</xref>
</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">wh18</td>
<td align="center">51</td>
<td align="center">K68S/N261L</td>
<td align="char" char="plusmn .">9.45&#x20;&#xb1; 1.44</td>
<td align="char" char="plusmn .">0.83&#x20;&#xb1; 0.05</td>
<td align="char" char=".">0.088</td>
<td align="char" char="plusmn .">0.118&#x20;&#xb1; 0.005</td>
</tr>
<tr>
<td align="left">wh27</td>
<td align="center">50</td>
<td align="center">K68S/N261L/I111F</td>
<td align="char" char="plusmn .">18.52&#x20;&#xb1; 1.42</td>
<td align="char" char="plusmn .">1.74&#x20;&#xb1; 0.07</td>
<td align="char" char=".">0.094</td>
<td align="char" char="plusmn .">0.177&#x20;&#xb1; 0.030</td>
</tr>
<tr>
<td align="left">wh81</td>
<td align="center">51</td>
<td align="center">K68S/N261L/I111F/V294C</td>
<td align="char" char="plusmn .">21.5&#x20;&#xb1; 3.37</td>
<td align="char" char="plusmn .">3.14&#x20;&#xb1; 0.27</td>
<td align="char" char=".">0.146</td>
<td align="char" char="plusmn .">0.362&#x20;&#xb1; 0.019</td>
</tr>
<tr>
<td align="left">wh84</td>
<td align="center">53</td>
<td align="center">K68S/N261L/I111F/E114V/V294C</td>
<td align="char" char="plusmn .">17.53&#x20;&#xb1; 1.11</td>
<td align="char" char="plusmn .">6.07&#x20;&#xb1; 0.19</td>
<td align="char" char=".">0.346</td>
<td align="char" char="plusmn .">0.884&#x20;&#xb1; 0.044</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="Tfn2">
<label>a</label>
<p>For determining thermostability, purified <italic>Sp</italic>AmDH enzymes (1&#xa0;mg/ml) were incubated at different temperatures (30&#x2013;70&#xb0;C) for 15&#xa0;min, followed by measuring the residual activity toward substrate&#x20;1a.</p>
</fn>
<fn id="Tfn3">
<label>b</label>
<p>For assaying kinetic parameters, the reaction was performed in 1&#xa0;M NH<sub>4</sub>Cl/NH<sub>3</sub>&#xb7;H<sub>2</sub>O buffer (pH 8.5) containing 0.2&#xa0;mM NADH and 0.5&#x2013;30&#xa0;mM substrate 1a, at optimum temperatures (50&#xb0;C) for 2&#xa0;min. Michaelis&#x2013;Menten plots are shown in <xref ref-type="sec" rid="s10">Supplementary Figure S2</xref>.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>Preparative-scale amination reactions were performed using whole-cell lysates as catalysts for the selected variants in 10&#xa0;ml of reaction volume, with 100&#xa0;mM substrate 1a. The mutant wh84 achieved an excellent conversion (&#x3e;99%), with the high enantioselectivity of &#x3e;99% ee within 18 h, while wh18 used as a control only showed ca. 80% conversion (<xref ref-type="fig" rid="F4">Figure&#x20;4A</xref>). (<italic>S</italic>)-2b was subsequently isolated as pure form (164&#xa0;mg, 62% yield) in the reaction system catalyzed by wh84. To further examine the catalytic potential of wh84, the concentration of 1a was raised up to 200&#xa0;mM. Interestingly, wh84 enabled 91% conversion (<xref ref-type="fig" rid="F4">Figure&#x20;4B</xref>).</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Preparative-scale of the asymmetric amination reactions of substrate 1a 100&#xa0;mM <bold>(A)</bold> and 200&#xa0;mM <bold>(B)</bold> catalyzed by wh18 and wh84 (&#x25a1;: wh18, &#x25b3;: wh84). Reaction system: 0.1&#xa0;g/ml wet cell, 1&#xa0;M NH<sub>4</sub>Cl/NH<sub>3</sub>&#xb7;H<sub>2</sub>O buffer (pH 8.5), 1&#xa0;mM NAD<sup>&#x2b;</sup>, 100&#xa0;mM glucose, 2&#xa0;mg/ml GDH CFE, 6 U/mL DNase I, 1&#xa0;mg/ml lysozyme, and 1a (100 and 200&#xa0;mM) were mixed in Erlenmeyer flask. The reaction was performed at 30&#xb0;C, 220&#xa0;rpm for 24&#xa0;h. The samples taken at 0, 1, 2, 3, 4, 8, 12, 18, and 24&#xa0;h were prepared and analyzed by HPLC.</p>
</caption>
<graphic xlink:href="fbioe-09-778584-g004.tif"/>
</fig>
</sec>
<sec id="s3-4">
<title>Gaining Insight on the Improved Activity of SpAmDH</title>
<p>In order to shed light on the improved activity of the <italic>Sp</italic>AmDH variant wh84, computational docking analyses were performed to gain insights into the relationship between reshaping of the active site and the effect on activity. The homology structure of wh84 was directly constructed based on the X-ray structure of <italic>Sp</italic>LeuDH (PDB ID: 3VPX, <xref ref-type="bibr" rid="B50">Zhao et&#x20;al., 2012</xref>) by introducing the corresponding mutations in PyMol program (<ext-link ext-link-type="uri" xlink:href="http://www.pymol.org/">http://www.pymol.org</ext-link>). After relaxing the initial structure of wh84, cofactor NADH, substrate 1a, and ammonium ion (NH<sub>4</sub>
<sup>&#x2b;</sup>) were docked into the active site one after another to generate the protein&#x2013;NADH-1a&#x2013;NH<sub>4</sub>
<sup>&#x2b;</sup> quaternary complex. It is of interest to note that the catalytic sites K80 and D115 form hydrogen bond interactions with the substrate carbonyl group and the ammonium ion, while the substitutions I111F, E114V, and V294C contribute to hydrophobic interactions with the substrate carbon chain (<xref ref-type="fig" rid="F5">Figure&#x20;5</xref>). These strengthened interactions may benefit the substrate recognition and orientation, thereby promoting the activity and maintaining the stereoselectivity. Moreover, on the basis of the proposed mechanism of the engineered AmDHs and their parent AADHs (<xref ref-type="bibr" rid="B38">Sharma et&#x20;al., 2017</xref>), this preferred binding orientation of 1a with respect to NADH determines the <italic>Re</italic> face of the C&#x3d;O bond undergoes nucleophilic attack and profits the (<italic>S</italic>)-configure product, which is consistent with the experimental results.</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>Docking analysis of substrate 1a in the catalytic pocket of the <italic>Sp</italic>AmDH variant wh84. Green lines and red spikes represent the hydrogen bonds and the penitential hydrophobic interactions, respectively. The cyan line indicates the nucleophilic attack. Distances are shown in angstroms.</p>
</caption>
<graphic xlink:href="fbioe-09-778584-g005.tif"/>
</fig>
</sec>
<sec id="s3-5">
<title>Substrate Scope Analysis Toward Other Prochiral Hydroxy ketones</title>
<p>With the aim to explore the catalytic potential of the engineered variants toward other prochiral hydroxy ketones, seven structurally different substrates were assayed using wh18, wh27, wh81, and wh84 as catalysts (<xref ref-type="fig" rid="F6">Figure&#x20;6</xref>). For the four aliphatic compounds 2a&#x2013;4a and cyclic ketone 8a, the variants showed high stereoselectivity (&#x3e;99%), and interestingly, the conversions were elevated from wh18 to wh84 in all the four cases (<xref ref-type="sec" rid="s10">Supplementary Figures S4&#x2013;S6, S10</xref>). For example, the conversion of 3a was improved from 43% (wh18) to 97% (wh84). However, in the scenario of the aromatic substrates, the four variants displayed relatively lower activity in the asymmetric reduction of 5a&#x2013;7a (<xref ref-type="fig" rid="F6">Figure&#x20;6</xref>), while the stereoselectivities were still inherently maintained (&#x3e;99%, <xref ref-type="sec" rid="s10">Supplementary Figures S7&#x2013;S9</xref>).</p>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption>
<p>Asymmetric transformations of hydroxy ketones. Reaction system: 0.1&#xa0;g/ml wet cell, 1&#xa0;M NH<sub>4</sub>Cl/NH<sub>3</sub>&#xb7;H<sub>2</sub>O buffer (pH 8.5), 1&#xa0;mM NAD<sup>&#x2b;</sup>, 100&#xa0;mM glucose, 2&#xa0;mg/ml GDH CFE, 6&#xa0;U/ml DNase I, 1&#xa0;mg/ml lysozyme, and 2a-8a (5&#xa0;mM) were mixed in 2&#xa0;ml Eppendorf tubes. The reaction was performed at 30&#xb0;C, 1,000&#xa0;rpm for 24&#xa0;h in a thermostatic metal bath. c, conversion; nd, not detectable.</p>
</caption>
<graphic xlink:href="fbioe-09-778584-g006.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="conclusion" id="s4">
<title>Conclusion</title>
<p>Reductive amination of carbonyl compounds employing AmDHs is an attractive route for the biosynthesis of chiral amino alcohols. It provides several advantages, including lower costs (the amino donor (NH<sub>4</sub>
<sup>&#x2b;</sup>) is inexpensive, and water is the main byproduct), elimination of heavy metals, and high stereoselectivity. As such, AmDHs have been reported in the selective synthesis of chiral compounds used as pharmaceutical intermediates. However, the limited catalytic efficiency can be a major obstacle to its industrial application. This work reports the engineering of <italic>Sp</italic>AmDH with the aim to improve the activity. After three rounds of CAST/ISM-guided mutagenesis, mutant wh84 was obtained with the best performance toward substrate 1a, resulting in an excellent TTN (32108) and a <italic>k</italic>
<sub>cat</sub>/<italic>K</italic>
<sub>m</sub> value of 0.346&#xa0;s<sup>&#x2212;1</sup>&#xa0;mM<sup>&#x2212;1</sup>, amounting to 3.2-fold and 3.9-fold improvements relative to the starting enzyme, respectively, while maintaining the high enantioselectivity (&#x3e;99% <italic>ee</italic>). In the 100&#xa0;mM preparative reaction, the conversion of 1a catalyzed by wh84 was up to 99% with a 62% yield, which is comparable with the recent work that employed an engineered AmDH from <italic>Lysinibacillus fusiformis</italic> as catalyst (<xref ref-type="bibr" rid="B6">Chen et&#x20;al., 2019</xref>).</p>
<p>Overall, this work paves the way toward engineering AmDHs with increased activity and also expands the biocatalytic toolbox for asymmetric reductive aminations, and should prove useful insights for further development of other AmDHs as catalysts in the biosynthesis of enantiopure amino alcohols.</p>
</sec>
</body>
<back>
<sec id="s5">
<title>Data Availability Statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="sec" rid="s10">Supplementary Material</xref>, and further inquiries can be directed to the corresponding authors.</p>
</sec>
<sec id="s6">
<title>Author Contributions</title>
<p>YX, ZS, and GQ designed and planned the study. FT, ZQ, HW, YJ, HM, and JL performed the experiments. GQ wrote the manuscript. All authors were involved in the discussions, planning the experiments, and editing manuscript.</p>
</sec>
<sec id="s7">
<title>Funding</title>
<p>This work was financially supported by the National Key Research and Development Program of China (No. 2019YFA0906400), the National Natural Science Foundation of China (No. 31870779), and the Tianjin Synthetic Biotechnology Innovation Capacity Improvement Project (TSBICIP-CXRC-009, TSBICIP-KJGG-003). GQ also thanks financial supports from the Youth Innovation Promotion Association (2021175),&#x20;CAS.</p>
</sec>
<sec sec-type="COI-statement" id="s8">
<title>Conflict of Interest</title>
<p>This work has been included in patent applications by the Tianjin Institute of Industrial Biotechnology.</p>
</sec>
<sec sec-type="disclaimer" id="s9">
<title>Publisher&#x2019;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors, and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s10">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fbioe.2021.778584/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fbioe.2021.778584/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet1.docx" id="SM1" mimetype="application/docx" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abrahamson</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>V&#xe1;zquez-Figueroa</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Woodall</surname>
<given-names>N. B.</given-names>
</name>
<name>
<surname>Moore</surname>
<given-names>J.&#x20;C.</given-names>
</name>
<name>
<surname>Bommarius</surname>
<given-names>A. S.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Development of an Amine Dehydrogenase for Synthesis of Chiral Amines</article-title>. <source>Angew. Chem. Int. Ed.</source> <volume>51</volume>, <fpage>3969</fpage>&#x2013;<lpage>3972</lpage>. <pub-id pub-id-type="doi">10.1002/anie.201107813</pub-id> </citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abrahamson</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>J.&#x20;W.</given-names>
</name>
<name>
<surname>Bommarius</surname>
<given-names>A. S.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>The Evolution of an Amine Dehydrogenase Biocatalyst for the Asymmetric Production of Chiral Amines</article-title>. <source>Adv. Synth. Catal.</source> <volume>355</volume>, <fpage>1780</fpage>&#x2013;<lpage>1786</lpage>. <pub-id pub-id-type="doi">10.1002/adsc.201201030</pub-id> </citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ager</surname>
<given-names>D. J.</given-names>
</name>
<name>
<surname>Prakash</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Schaad</surname>
<given-names>D. R.</given-names>
</name>
</person-group> (<year>1996</year>). <article-title>1,2-Amino Alcohols and Their Heterocyclic Derivatives as Chiral Auxiliaries in Asymmetric Synthesis</article-title>. <source>Chem. Rev.</source> <volume>96</volume>, <fpage>835</fpage>&#x2013;<lpage>876</lpage>. <pub-id pub-id-type="doi">10.1021/cr9500038</pub-id> </citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Au</surname>
<given-names>S. K.</given-names>
</name>
<name>
<surname>Bommarius</surname>
<given-names>B. R.</given-names>
</name>
<name>
<surname>Bommarius</surname>
<given-names>A. S.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Biphasic Reaction System Allows for Conversion of Hydrophobic Substrates by Amine Dehydrogenases</article-title>. <source>ACS Catal.</source> <volume>4</volume>, <fpage>4021</fpage>&#x2013;<lpage>4026</lpage>. <pub-id pub-id-type="doi">10.1021/cs4012167</pub-id> </citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Breuer</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ditrich</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Habicher</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Hauer</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Kesseler</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>St&#xfc;rmer</surname>
<given-names>R.</given-names>
</name>
<etal/>
</person-group> (<year>2004</year>). <article-title>Industrial Methods for the Production of Optically Active Intermediates</article-title>. <source>Angew. Chem. Int. Ed.</source> <volume>43</volume>, <fpage>788</fpage>&#x2013;<lpage>824</lpage>. <pub-id pub-id-type="doi">10.1002/anie.200300599</pub-id> </citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>F.-F.</given-names>
</name>
<name>
<surname>Cosgrove</surname>
<given-names>S. C.</given-names>
</name>
<name>
<surname>Birmingham</surname>
<given-names>W. R.</given-names>
</name>
<name>
<surname>Mangas-Sanchez</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Citoler</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Thompson</surname>
<given-names>M. P.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Enantioselective Synthesis of Chiral Vicinal Amino Alcohols Using Amine Dehydrogenases</article-title>. <source>ACS Catal.</source> <volume>9</volume>, <fpage>11813</fpage>&#x2013;<lpage>11818</lpage>. <pub-id pub-id-type="doi">10.1021/acscatal.9b03889</pub-id> </citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>F.-F.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.-Y.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>G.-W.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>J.-H.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Asymmetric Amination of Secondary Alcohols by Using a Redox-Neutral Two-Enzyme Cascade</article-title>. <source>ChemCatChem</source> <volume>7</volume>, <fpage>3838</fpage>&#x2013;<lpage>3841</lpage>. <pub-id pub-id-type="doi">10.1002/cctc.201500785</pub-id> </citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>F.-F.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>G.-W.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>F.-L.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Reshaping the Active Pocket of Amine Dehydrogenases for Asymmetric Synthesis of Bulky Aliphatic Amines</article-title>. <source>ACS Catal.</source> <volume>8</volume>, <fpage>2622</fpage>&#x2013;<lpage>2628</lpage>. <pub-id pub-id-type="doi">10.1021/acscatal.7b04135</pub-id> </citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Arnold</surname>
<given-names>F. H.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Engineering New Catalytic Activities in Enzymes</article-title>. <source>Nat. Catal.</source> <volume>3</volume>, <fpage>203</fpage>&#x2013;<lpage>213</lpage>. <pub-id pub-id-type="doi">10.1038/s41929-019-0385-5</pub-id> </citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Combs</surname>
<given-names>S. A.</given-names>
</name>
<name>
<surname>Deluca</surname>
<given-names>S. L.</given-names>
</name>
<name>
<surname>Deluca</surname>
<given-names>S. H.</given-names>
</name>
<name>
<surname>Lemmon</surname>
<given-names>G. H.</given-names>
</name>
<name>
<surname>Nannemann</surname>
<given-names>D. P.</given-names>
</name>
<name>
<surname>Nguyen</surname>
<given-names>E. D.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>Small-molecule Ligand Docking into Comparative Models with Rosetta</article-title>. <source>Nat. Protoc.</source> <volume>8</volume>, <fpage>1277</fpage>&#x2013;<lpage>1298</lpage>. <pub-id pub-id-type="doi">10.1038/nprot.2013.074</pub-id> </citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Conway</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Tyka</surname>
<given-names>M. D.</given-names>
</name>
<name>
<surname>DiMaio</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Konerding</surname>
<given-names>D. E.</given-names>
</name>
<name>
<surname>Baker</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Relaxation of Backbone Bond Geometry Improves Protein Energy Landscape Modeling</article-title>. <source>Protein Sci.</source> <volume>23</volume>, <fpage>47</fpage>&#x2013;<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1002/pro.2389</pub-id> </citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Erlanson</surname>
<given-names>D. A.</given-names>
</name>
<name>
<surname>Arndt</surname>
<given-names>J.&#x20;W.</given-names>
</name>
<name>
<surname>Cancilla</surname>
<given-names>M. T.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Elling</surname>
<given-names>R. A.</given-names>
</name>
<name>
<surname>English</surname>
<given-names>N.</given-names>
</name>
<etal/>
</person-group> (<year>2011</year>). <article-title>Discovery of a Potent and Highly Selective PDK1 Inhibitor via Fragment-Based Drug Discovery</article-title>. <source>Bioorg. Med. Chem. Lett.</source> <volume>21</volume>, <fpage>3078</fpage>&#x2013;<lpage>3083</lpage>. <pub-id pub-id-type="doi">10.1016/j.bmcl.2011.03.032</pub-id> </citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Francalanci</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Cesti</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Cabri</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Bianchi</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Martinengo</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Foa</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>1987</year>). <article-title>Lipase-Catalyzed Resolution of Chiral 2-amino 1-alcohols</article-title>. <source>J.&#x20;Org. Chem.</source> <volume>52</volume>, <fpage>5079</fpage>&#x2013;<lpage>5082</lpage>. <pub-id pub-id-type="doi">10.1021/jo00232a002</pub-id> </citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Franklin</surname>
<given-names>R. D.</given-names>
</name>
<name>
<surname>Mount</surname>
<given-names>C. J.</given-names>
</name>
<name>
<surname>Bommarius</surname>
<given-names>B. R.</given-names>
</name>
<name>
<surname>Bommarius</surname>
<given-names>A. S.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Separate Sets of Mutations Enhance Activity and Substrate Scope of Amine Dehydrogenase</article-title>. <source>ChemCatChem</source> <volume>12</volume>, <fpage>2436</fpage>&#x2013;<lpage>2439</lpage>. <pub-id pub-id-type="doi">10.1002/cctc.201902364</pub-id> </citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hollmann</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Opperman</surname>
<given-names>D. J.</given-names>
</name>
<name>
<surname>Paul</surname>
<given-names>C. E.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Biocatalytic Reduction Reactions From a Chemist&#x2019;s Perspective</article-title>. <source>Angew. Chem. Int. Ed.</source> <volume>60</volume>, <fpage>5644</fpage>&#x2013;<lpage>5665</lpage>. <pub-id pub-id-type="doi">10.1002/anie.20180034310.1002/anie.202001876</pub-id> </citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Itoh</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Yachi</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Kudome</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>Determining a Novel NAD&#x2b;-dependent Amine Dehydrogenase with a Broad Substrate Range from Streptomyces Virginiae IFO 12827: Purification and Characterization</article-title>. <source>J.&#x20;Mol. Catal. B: Enzymatic</source> <volume>10</volume>, <fpage>281</fpage>&#x2013;<lpage>290</lpage>. <pub-id pub-id-type="doi">10.1016/S1381-1177(00)00111-9</pub-id> </citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Karjalainen</surname>
<given-names>O. K.</given-names>
</name>
<name>
<surname>Koskinen</surname>
<given-names>A. M. P.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Diastereoselective Synthesis of Vicinal Amino Alcohols</article-title>. <source>Org. Biomol. Chem.</source> <volume>10</volume>, <fpage>4311</fpage>&#x2013;<lpage>4326</lpage>. <pub-id pub-id-type="doi">10.1039/C2OB25357G</pub-id> </citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Larrow</surname>
<given-names>J.&#x20;F.</given-names>
</name>
<name>
<surname>Schaus</surname>
<given-names>S. E.</given-names>
</name>
<name>
<surname>Jacobsen</surname>
<given-names>E. N.</given-names>
</name>
</person-group> (<year>1996</year>). <article-title>Kinetic Resolution of Terminal Epoxides via Highly Regioselective and Enantioselective Ring Opening with TMSN3. An Efficient, Catalytic Route to 1,2-Amino Alcohols</article-title>. <source>J.&#x20;Am. Chem. Soc.</source> <volume>118</volume>, <fpage>7420</fpage>&#x2013;<lpage>7421</lpage>. <pub-id pub-id-type="doi">10.1021/ja961708&#x2b;</pub-id> </citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Jeon</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Giri</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>U.-J.</given-names>
</name>
<name>
<surname>Jung</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Lim</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>The Reductive Amination of Carbonyl Compounds Using Native Amine Dehydrogenase from <italic>Laribacter hongkongensis</italic>
</article-title>. <source>Biotechnol. Bioproc. E.</source> <volume>26</volume>, <fpage>384</fpage>&#x2013;<lpage>391</lpage>. <pub-id pub-id-type="doi">10.1007/s12257-021-0113-2</pub-id> </citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Q.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Directed Evolution of Lipase A from <italic>Bacillus Subtilis</italic> for the Preparation of Enantiocomplementary <italic>Sec</italic>-Alcohols</article-title>. <source>Green. Synth. Catal.</source> <volume>2</volume>, <fpage>290</fpage>&#x2013;<lpage>294</lpage>. <pub-id pub-id-type="doi">10.1016/j.gresc.2021.07.003</pub-id> </citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Qu</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Shang</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Men</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>W.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Near-Perfect Control of the Regioselective Glucosylation Enabled by Rational Design of Glycosyltransferases</article-title>. <source>Green. Synth. Catal.</source> <volume>2</volume>, <fpage>45</fpage>&#x2013;<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1016/j.gresc.2021.01.005</pub-id> </citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>D.-H.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>F.-F.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Z.-J.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>J.-H.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Development of an Engineered Thermostable Amine Dehydrogenase for the Synthesis of Structurally Diverse Chiral Amines</article-title>. <source>Catal. Sci. Technol.</source> <volume>10</volume>, <fpage>2353</fpage>&#x2013;<lpage>2358</lpage>. <pub-id pub-id-type="doi">10.1039/D0CY00071J</pub-id> </citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ma</surname>
<given-names>S. K.</given-names>
</name>
<name>
<surname>Gruber</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Newman</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Gray</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2010</year>). <article-title>A Green-by-Design Biocatalytic Process for Atorvastatin Intermediate</article-title>. <source>Green. Chem.</source> <volume>12</volume>, <fpage>81</fpage>&#x2013;<lpage>86</lpage>. <pub-id pub-id-type="doi">10.1039/B919115C</pub-id> </citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Matzel</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Gand</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>H&#xf6;hne</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>One-step Asymmetric Synthesis of (<italic>R</italic>)- and (<italic>S</italic>)-rasagiline by Reductive Amination Applying Imine Reductases</article-title>. <source>Green. Chem.</source> <volume>19</volume>, <fpage>385</fpage>&#x2013;<lpage>389</lpage>. <pub-id pub-id-type="doi">10.1039/c6gc03023h</pub-id> </citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mayol</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Bastard</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Beloti</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Frese</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Turkenburg</surname>
<given-names>J.&#x20;P.</given-names>
</name>
<name>
<surname>Petit</surname>
<given-names>J.-L.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>A Family of Native Amine Dehydrogenases for the Asymmetric Reductive Amination of Ketones</article-title>. <source>Nat. Catal.</source> <volume>2</volume>, <fpage>324</fpage>&#x2013;<lpage>333</lpage>. <pub-id pub-id-type="doi">10.1038/s41929-019-0249-z</pub-id> </citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mei</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Qu</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J.-K.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>J.-A.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>High-throughput Fluorescence Assay for Ketone Detection and its Applications in Enzyme Mining and Protein Engineering</article-title>. <source>ACS Omega</source> <volume>5</volume>, <fpage>13588</fpage>&#x2013;<lpage>13594</lpage>. <pub-id pub-id-type="doi">10.1021/acsomega.0c00245</pub-id> </citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nugent</surname>
<given-names>T. C.</given-names>
</name>
<name>
<surname>El-Shazly</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Chiral Amine Synthesis - Recent Developments and Trends for Enamide Reduction, Reductive Amination, and Imine Reduction</article-title>. <source>Adv. Synth. Catal.</source> <volume>352</volume>, <fpage>753</fpage>&#x2013;<lpage>819</lpage>. <pub-id pub-id-type="doi">10.1002/adsc.200900719</pub-id> </citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pablos-M&#xe9;ndez</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Raviglione</surname>
<given-names>M. C.</given-names>
</name>
<name>
<surname>Laszlo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Binkin</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Rieder</surname>
<given-names>H. L.</given-names>
</name>
<name>
<surname>Bustreo</surname>
<given-names>F.</given-names>
</name>
<etal/>
</person-group> (<year>1998</year>). <article-title>Global Surveillance for Antituberculosis-Drug Resistance, 1994-1997</article-title>. <source>N. Engl. J.&#x20;Med.</source> <volume>338</volume>, <fpage>1641</fpage>&#x2013;<lpage>1649</lpage>. <pub-id pub-id-type="doi">10.1056/nejm199806043382301</pub-id> </citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Patil</surname>
<given-names>M. D.</given-names>
</name>
<name>
<surname>Grogan</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Bommarius</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Yun</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Oxidoreductase-Catalyzed Synthesis of Chiral Amines</article-title>. <source>ACS Catal.</source> <volume>8</volume>, <fpage>10985</fpage>&#x2013;<lpage>11015</lpage>. <pub-id pub-id-type="doi">10.1021/acscatal.8b02924</pub-id> </citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pushpanath</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Siirola</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Bornadel</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Woodlock</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Schell</surname>
<given-names>U.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Understanding and Overcoming the Limitations of <italic>Bacillus badius</italic> and <italic>Caldalkalibacillus thermarum</italic> Amine Dehydrogenases for Biocatalytic Reductive Amination</article-title>. <source>ACS Catal.</source> <volume>7</volume>, <fpage>3204</fpage>&#x2013;<lpage>3209</lpage>. <pub-id pub-id-type="doi">10.1021/acscatal.7b00516</pub-id> </citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qu</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Acevedo&#x2010;Rocha</surname>
<given-names>C. G.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Reetz</surname>
<given-names>M. T.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>The Crucial Role of Methodology Development in Directed Evolution of Selective Enzymes</article-title>. <source>Angew. Chem. Int. Ed.</source> <volume>59</volume>, <fpage>13204</fpage>&#x2013;<lpage>13231</lpage>. <pub-id pub-id-type="doi">10.1002/anie.201901491</pub-id> </citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qu</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Nie</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Z.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Laboratory Evolution of an Alcohol Dehydrogenase Towards Enantioselective Reduction of Difficult-to-Reduce Ketones</article-title>. <source>Bioresour. Bioproc.</source> <volume>6</volume>, <fpage>18</fpage>. <pub-id pub-id-type="doi">10.1186/s40643-019-0253-9</pub-id> </citation>
</ref>
<ref id="B33">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Qu</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Reetz</surname>
<given-names>M. T.</given-names>
</name>
</person-group> (<year>2021</year>). &#x201c;<article-title>Iterative Saturation Mutagenesis for Semi&#x2010;rational Enzyme Design</article-title>,&#x201d; in <source>Protein Engineering: Tools and Applications</source>. Editor <person-group person-group-type="editor">
<name>
<surname>Zhao</surname>
<given-names>H.</given-names>
</name>
</person-group> (<publisher-loc>Weinheim</publisher-loc>: <publisher-name>Wiley-VCH Press</publisher-name>), <fpage>105</fpage>&#x2013;<lpage>132</lpage>. <pub-id pub-id-type="doi">10.1002/9783527815128.ch5</pub-id> </citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reetz</surname>
<given-names>M. T.</given-names>
</name>
<name>
<surname>Bocola</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Carballeira</surname>
<given-names>J.&#x20;D.</given-names>
</name>
<name>
<surname>Zha</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Vogel</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Expanding the Range of Substrate Acceptance of Enzymes: Combinatorial Active-Site Saturation Test</article-title>. <source>Angew. Chem. Int. Ed.</source> <volume>44</volume>, <fpage>4192</fpage>&#x2013;<lpage>4196</lpage>. <pub-id pub-id-type="doi">10.1002/anie.200500767</pub-id> </citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reetz</surname>
<given-names>M. T.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Laboratory Evolution of Stereoselective Enzymes: a Prolific Source of Catalysts for Asymmetric Reactions</article-title>. <source>Angew. Chem. Int. Ed.</source> <volume>50</volume>, <fpage>138</fpage>&#x2013;<lpage>174</lpage>. <pub-id pub-id-type="doi">10.1002/anie.201000826</pub-id> </citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schrittwieser</surname>
<given-names>J.&#x20;H.</given-names>
</name>
<name>
<surname>Velikogne</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kroutil</surname>
<given-names>W.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Biocatalytic Imine Reduction and Reductive Amination of Ketones</article-title>. <source>Adv. Synth. Catal.</source> <volume>357</volume>, <fpage>1655</fpage>&#x2013;<lpage>1685</lpage>. <pub-id pub-id-type="doi">10.1002/adsc.201500213</pub-id> </citation>
</ref>
<ref id="B37">
<citation citation-type="book">
<collab>Schr&#xf6;dinger</collab> (<year>2015</year>). <source>Schr&#xf6;dinger Suite 2015-1</source>. <publisher-loc>New York</publisher-loc>: <publisher-name>LLC</publisher-name>. </citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sharma</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mangas-Sanchez</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Turner</surname>
<given-names>N. J.</given-names>
</name>
<name>
<surname>Grogan</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>NAD(P)H-dependent Dehydrogenases for the Asymmetric Reductive Amination of Ketones: Structure, Mechanism, Evolution and Application</article-title>. <source>Adv. Synth. Catal.</source> <volume>359</volume>, <fpage>2011</fpage>&#x2013;<lpage>2025</lpage>. <pub-id pub-id-type="doi">10.1002/adsc.201700356</pub-id> </citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Lonsdale</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Reetz</surname>
<given-names>M. T.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Comparing Different Strategies in Directed Evolution of Enzyme Stereoselectivity: Single- Versus Double-Code Saturation Mutagenesis</article-title>. <source>ChemBioChem</source> <volume>17</volume>, <fpage>1865</fpage>&#x2013;<lpage>1872</lpage>. <pub-id pub-id-type="doi">10.1002/cbic.201600296</pub-id> </citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Trott</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Olson</surname>
<given-names>A. J.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>AutoDock Vina: Improving the Speed and Accuracy of Docking with a New Scoring Function, Efficient Optimization, and Multithreading</article-title>. <source>J.&#x20;Comput. Chem.</source> <volume>31</volume>, <fpage>455</fpage>&#x2013;<lpage>461</lpage>. <pub-id pub-id-type="doi">10.1002/jcc.21334</pub-id> </citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tyagi</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Lai</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Duggleby</surname>
<given-names>R. G.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>A New Approach to &#x2018;megaprimer&#x2019; Polymerase Chain Reaction Mutagenesis Without an Intermediate Gel Purification Step</article-title>. <source>BMC Biotechnol.</source> <volume>4</volume>, <fpage>2</fpage>. <pub-id pub-id-type="doi">10.1186/1472-6750-4-2</pub-id> </citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Qu</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J.-K.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>J.-A.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Miao</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Data Mining of Amine Dehydrogenases for the Synthesis of Enantiopure Amino Alcohols</article-title>. <source>Catal. Sci. Technol.</source> <volume>10</volume>, <fpage>5945</fpage>&#x2013;<lpage>5952</lpage>. <pub-id pub-id-type="doi">10.1039/D0CY01373K</pub-id> </citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Efficient Continuous Kinetic Resolution of Racemic 2-Aminobutanol Over Immobilized Penicillin G Acylase</article-title>. <source>Synth. Commun.</source> <volume>46</volume>, <fpage>956</fpage>&#x2013;<lpage>962</lpage>. <pub-id pub-id-type="doi">10.1080/00397911.2016.1181763</pub-id> </citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Winkler</surname>
<given-names>C. K.</given-names>
</name>
<name>
<surname>Schrittwieser</surname>
<given-names>J.&#x20;H.</given-names>
</name>
<name>
<surname>Kroutil</surname>
<given-names>W.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Power of Biocatalysis for Organic Synthesis</article-title>. <source>ACS Cent. Sci.</source> <volume>7</volume>, <fpage>55</fpage>&#x2013;<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1021/acscentsci.0c01496</pub-id> </citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>H.-L.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J.-D.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>C.-F.</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>X.-J.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>H.-H.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>W.-L.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Characterization of Four New Distinct &#x3c9;-Transaminases from Pseudomonas Putida NBRC 14164 for Kinetic Resolution of Racemic Amines and Amino Alcohols</article-title>. <source>Appl. Biochem. Biotechnol.</source> <volume>181</volume>, <fpage>972</fpage>&#x2013;<lpage>985</lpage>. <pub-id pub-id-type="doi">10.1007/s12010-016-2263-9</pub-id> </citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Snajdrova</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Moore</surname>
<given-names>J.&#x20;C.</given-names>
</name>
<name>
<surname>Baldenius</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Bornscheuer</surname>
<given-names>U. T.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Biocatalysis: Enzymatic Synthesis for Industrial Applications</article-title>. <source>Angew. Chem. Int. Ed.</source> <volume>60</volume>, <fpage>88</fpage>&#x2013;<lpage>119</lpage>. <pub-id pub-id-type="doi">10.1002/anie.202006648</pub-id> </citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xie</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Hua</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Ambient-temperature Synthesis of Primary Amines via Reductive Amination of Carbonyl Compounds</article-title>. <source>ACS Catal.</source> <volume>10</volume>, <fpage>7763</fpage>&#x2013;<lpage>7772</lpage>. <pub-id pub-id-type="doi">10.1021/acscatal.0c01872</pub-id> </citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yanai</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Sindoro</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Granick</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Electric Field-Induced Assembly of Monodisperse Polyhedral Metal-Organic Framework Crystals</article-title>. <source>J.&#x20;Am. Chem. Soc.</source> <volume>135</volume>, <fpage>34</fpage>&#x2013;<lpage>37</lpage>. <pub-id pub-id-type="doi">10.1021/ja309361d</pub-id> </citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ye</surname>
<given-names>L. J.</given-names>
</name>
<name>
<surname>Toh</surname>
<given-names>H. H.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Adams</surname>
<given-names>J.&#x20;P.</given-names>
</name>
<name>
<surname>Snajdrova</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Z.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Engineering of Amine Dehydrogenase for Asymmetric Reductive Amination of Ketone by Evolving <italic>Rhodococcus</italic> Phenylalanine Dehydrogenase</article-title>. <source>ACS Catal.</source> <volume>5</volume>, <fpage>1119</fpage>&#x2013;<lpage>1122</lpage>. <pub-id pub-id-type="doi">10.1021/cs501906r</pub-id> </citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wakamatsu</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Doi</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Sakuraba</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ohshima</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>A Psychrophilic Leucine Dehydrogenase from <italic>Sporosarcina psychrophila</italic>: Purification, Characterization, Gene Sequencing and Crystal Structure Analysis</article-title>. <source>J.&#x20;Mol. Catal. B Enzym.</source> <volume>83</volume>, <fpage>65</fpage>&#x2013;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcatb.2012.06.018</pub-id> </citation>
</ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zheng</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Directed Evolution of L-Threonine Aldolase for the Diastereoselective Synthesis of &#x3b2;-Hydroxy-&#x3b1;-Amino Acids</article-title>. <source>ACS Catal.</source> <volume>11</volume>, <fpage>3198</fpage>&#x2013;<lpage>3205</lpage>. <pub-id pub-id-type="doi">10.1021/acscatal.0c04949</pub-id> </citation>
</ref>
</ref-list>
</back>
</article>